Used in biomedical research to detect and quantify neutrophil gelatinase-associated lipocalin (NGAL), a biomarker for early acute kidney injury. The kit enables researchers to measure NGAL levels in biological samples such as urine, serum, or plasma, allowing for rapid assessment of kidney damage in experimental models or clinical studies. It is widely applied in nephrotoxicity screening, monitoring renal function in critical care settings, and evaluating kidney injury in response to drugs, infections, or surgical procedures. The ELISA format provides high sensitivity and specificity, making it a valuable tool in both preclinical and translational research.